CAS: 2227199-31-5
Ref: 4Z-T-117102
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Friday 17 May 2024
Butyl 3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate
Controlled ProductCAS:2227199-31-5
Applications N-Butyl 3-oxopropanoate Tofacitinib is an impurity of Tofacitinib(T528000) which is an enantiopure stereoisomer of …
Formula:
C20H29N5O3
Molecular weight:
387.476
Ref: TR-B357450
100mg | 2,167.00 € |
Estimated delivery in United States, on Thursday 20 Jun 2024
Butyl 3-[4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanoate
CAS:2227199-31-5
Please enquire for more information about Butyl 3-[4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanoate including the price, delivery time and more …
Formula:
C20H29N5O3
Purity:
Min. 95%
Molecular weight:
387.5 g/mol
Ref: 3D-CPD19931
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Friday 21 Jun 2024